Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% single-use eye drops |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% single-use eye drops |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 50 mg/g eye drops |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% preservative-free eye drops |
Is a |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride [CVS sympathomimetic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine HCl [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 50 mg/g eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 100 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 1% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Acetaminophen + chlorpheniramine maleate + phenylephrine hydrochloride 500mg/8mg/40mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride + phenylephrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Acetaminophen + chlorpheniramine maleate + phenylephrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 1% (10mg/mL) injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 1% (10mg/mL) injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 1% (10mg/mL) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Phenylephrine hydrochloride 10% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 2.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 50 mg/g eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 50 mg/g eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 2.5% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 2.5% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 100 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 100 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg/mL nasal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 10 mg/mL nasal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 25 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 25 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Phenylephrine (as phenylephrine hydrochloride) 50 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenylephrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |